Seqens

Ecully, France · Founded 2003 · Privately Held (backing)

Manufacturer of pharmaceutical ingredients and specialty ingredients based in Ecully, France. Seqens is based in Ecully, France and was founded in 2003. Its last reported valuation was $1.6 billion in Nov 2022. It has raised $544 million.

Last reported valuation
$1.6B
Oct 2026
Priced at
—
Total raised
$543.8M
Last round
—

Who backs Seqens?

8 investors
InvestorType
BpifranceOther
Societe Generale Capital PartenairesPE / buyout
Caisse des Depots GroupOther
Crescent Capital GroupAsset manager
EximiumFamily office
RhodiaOther
SK Capital PartnersPE / buyout
Merieux Equity Partners (Lyon)—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Seqens investors

Free account
More of Seqens with a free account
  • ·Watch Seqens: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 8 firms already write checks for companies like Seqens. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View